ArticleCancer letters2013

Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization.

Kevin P Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.